Combinatorial Screening Using Orthotopic Patient Derived Xenograft-Expanded Early Phase Cultures of Osteosarcoma Identify Novel Therapeutic Drug Combinations

Lead discovery in osteosarcoma has been hampered by the lack of new agents, limited representative clinical samples and paucity of accurate preclinical models. We developed orthotopic patient-derived xenografts (PDXs) that recapitulated the molecular, cellular and histologic features of primary tumo...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Cancer Lett
Päätekijät: Loh, Amos H.P., Stewart, Elizabeth, Bradley, Cori L., Chen, Xiang, Daryani, Vinay, Stewart, Clinton F., Calabrese, Christopher, Funk, Amy, Miller, Greg, Karlstrom, Asa, Krafcik, Fred, Goshorn, David R., Vogel, Peter, Bahrami, Armita, Shelat, Anang, Dyer, Michael A.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2018
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6342199/
https://ncbi.nlm.nih.gov/pubmed/30395907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2018.10.033
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia